Mode
Text Size
Log in / Sign up

Cardiac MRI Integration Enhances Consistency in Heart Team Revascularization DecisionsHeart imaging helps medical teams agree on heart surgery decisions

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
CMR findings improve the consistency of heart-team revascularization decisions in patients with ischemic cardiomyopathy.

This observational study evaluated the impact of cardiac MRI (CMR) on heart-team decision-making for patients with ischemic cardiomyopathy. By incorporating CMR findings into the clinical workflow, the study aimed to determine if imaging data could reduce variability in revascularization recommendations.

Results indicated that the inclusion of CMR data led to a statistically significant increase in the consistency of treatment decisions across different heart teams. This suggests that CMR provides valuable anatomical and functional information that aligns clinical perspectives during the decision-making process.

While the study explored the relationship between the residual viable SYNTAX score and clinical outcomes, no statistically significant associations were found. However, the researchers noted that this specific scoring metric remains unvalidated and the clinical outcome data were primarily exploratory.

Due to the small sample size and the presence of non-independent observations, these findings should be interpreted with caution. Future studies with larger cohorts and cluster-aware statistical methods are necessary to confirm the impact of CMR on long-term clinical outcomes.

When doctors decide how to treat a patient with a damaged heart, they need clear information to make the right call. This study looked at how heart imaging, specifically cardiac MRI, helped a team of specialists decide on the best surgical path for 64 patients.

Researchers found that including these detailed images led to more consistent treatment decisions across different teams. By seeing the heart's condition more clearly, the experts were more likely to agree on the best way forward. This suggests that imaging can act as a helpful guide when making complex choices for patients with ischemic cardiomyopathy.

While the results are promising, the study had some limitations. The group of patients was small, and the specific scoring system used to predict outcomes is not yet fully validated. Because of these factors, the findings should be viewed as a helpful starting point that needs more research to confirm.

What this means for you:
Heart imaging helps medical teams reach more consistent agreements on how to treat heart muscle damage.

Common questions

How does heart imaging help doctors?

Cardiac MRI provides detailed images of the heart. In this study, including these images helped medical teams reach more consistent decisions when deciding on the best treatment for patients with heart muscle damage. It helped the team agree more often on the best path forward.

Is this a proven treatment for heart disease?

The study shows that imaging helps doctors make better decisions, but it is not a treatment itself. Because the study had a small sample size and used some unvalidated scores, the results are not definitive and need more research to be fully confirmed.

Study Details

Study typeGuideline
EvidenceLevel 5
PublishedSep 2026
View Original Abstract ↓
AimsOur study aims to evaluate the influence of myocardial viability on therapeutic decision-making using cardiac MRI (CMR) and assess agreement and variability in heart-team therapeutic recommendations across different heart teams.MethodologyWe included patients who underwent coronary angiography and CMR between January 2022 and January 2024 at a tertiary cardiac center. The revascularization strategy was independently determined by heart teams from four different centers, both before and after a review of CMR. The impact of CMR on therapeutic decisions was evaluated with a follow-up for long-term outcomes, while decision concordance before and after CMR was assessed using Cohen's kappa statistics. We calculated a novel residual viable syntax score by incorporating the myocardial viability into the residual syntax score.ResultsSixty-four patients were recruited. Indications for coronary angiography included ST elevation myocardial infarction (23, 36%), NSTEMI (15, 23.4%), unstable angina (7, 10.9%), and chronic coronary syndrome with limiting symptoms (19, 29.7%). Fifty-five (86%) patients had moderate to severe LV dysfunction. A proportion of 32.8% of the patients underwent revascularization in the study population in the form of coronary artery bypass grafting or percutaneous coronary intervention, while the rest were managed medically. Incorporation of CMR findings improved the consistency of treatment decisions across heart teams (Δκ =  + 0.114, 95% confidence interval 0.01–0.22); however, these estimates should be interpreted cautiously because a total of 512 recommendations arose from repeated assessments of 64 patients and were not independent observations. Clinical-outcome analyses were exploratory because only 13 patients experienced major adverse cardiovascular outcomes during follow-up. The exploratory, non-validated residual viable SYNTAX score was not statistically significantly associated with clinical outcomes.ConclusionCMR influenced heart-team revascularization recommendations and was associated with greater agreement in therapeutic decisions. These findings, including exploratory clinical-outcome analyses, require confirmation in larger studies that use cluster-aware statistical methods.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.